" />

Central Nervous System

Ensuring accurate outcomes
Trials for central nervous system disorders are very complex and, these trials are gaining importance in every pharmaceutical company.

In central nervous system diseases, new pharmacologic treatments must show a meaningful clinical advantage over existing standard-of-care treatments to gain regulatory approval and achieve commercial success. Designing and executing clinical trials to measure these advantages requires careful consideration of several factors, which includes:
  • Unmet medical needs
  • Use of placebos
  • Drug-drug interactions
  • Implementation of rating scales and relevant social, cultural and regulatory differences between geographic regions
  • Leveraging expertise in protocol design, biomarker strategies and diagnostic imaging technologies that are opening doors for CNS research

SIRO's experienced clinical operations and medical team ensures that the client gets the best result. As outcome measures are subjective our team provides extensive training to investigators to ensure that results are accurate. The worldwide reach of SIRO helps to streamline varying operations from its different sites. Every single project delivered is high quality and carefully monitored by the senior management.

We have extensive experience in the following indications:
  • Schizophrenia
  • Bipolar disorder
  • Depression
  • Neuropathic pain
  • Alzheimer's disease
  • Acute ischemic stroke

Additional Resources
Case Studies:
Central nervous diseases case studies